Depletion of circTLK1 mitigates dopaminergic neuron injury in vitro and in vivo, via releasing miR-26a-5p to target DAPK1 expression. Targeting circTLK1 may contribute to improving PD therapy.
Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson disease by targeting miR-26a-5p/DAPK1.